Skip to main content
Contact Us
Subscriber Sign In
navigation
サイト内検索
What We Do
Commercial Intelligence
Products
Evaluate Pharma
Evaluate Omnium
Evaluate Medtech
Evaluate Epi
Japan Drug Forecasts
Europe Drug Forecasts
CDMO Intelligence
Real World Data
Pharma Consulting & Analytics
Pharma Consulting & Analytics
Data Feeds
Evaluate Vantage
News
Analysis
Policy & Pricing
Insights
Events
Medtech
Therapy Areas
Evaluate for Biotech
How We Can Help You
Pharma and Biotech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
Multimedia
Blog
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Contact Us
Sign Up for Evaluate Vantage
Talent
Subscriber Sign In
Search
Open configuration options
Search
Vantage
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
Breadcrumb
Home
Vantage
Pharmaceutical Companies
Advanced Biohealing
Evaluate
October 16, 2014
Therapeutic focus – Beyond the bandage for venous ulcers
August 14, 2013
Stem cells get a win as Osiris's Grafix impresses in diabetic foot ulcers
February 07, 2013
M&A activity cools in 2012 as break-ups loom
May 24, 2012
Stem cell therapies needing more regulatory acceptance
February 01, 2012
Average M&A deal values recover in 2011
September 29, 2011
Therapeutic Focus - Diabetic foot ulcer market in need of healing
August 25, 2011
Shire loses with Dermagraft and wins with Firazyr
August 23, 2011
Encouraging 2011 M&A trends seen but big pharma inactivity concerning
July 18, 2011
Spotting the opportunities in the dermatology market
July 12, 2011
Tough IPO scene continues in first half 2011
May 23, 2011
BioEquity - Big pharma slowing the pace of deals
Load More
Latest Reports
July 27, 2023
H1 Round Up: The haves and the have-nots
July 21, 2023
ADA/EASL eBook
Editor's Picks
July 03, 2023
Astrazeneca and Daiichi’s big reveal disappoints
July 13, 2023
Pharma finds a way to gain weight
July 03, 2023
Protagonist investors flake as psoriasis pill disappoints
June 29, 2023
Approaching datasets for big pharma
June 27, 2023
Nkarta goes back to basics